Mazokalim

This classification denotes an antihypertensive agent with the molecular formula C23H28N6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K3N608EC7L, chemically known as ethyl 5-((3s,4r)-4-((1,6-dihydro-6-oxo-3-pyridazinyl)oxy)-3-hydroxy-2,2,3-trimethyl-6-chromanyl)-1h-tetrazole-1-butyrate. but generally known as mazokalim, which bears US NIH Compound Identifier 3045404. European Medicines Agency schedules Mazokalim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08658MIG. The term MAZOKALIM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, No. 11997, List 37). MAZOKALIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mazokalim under HS 29349990 and SITC 51579. As of Q4 2014, MAZOKALIM remains the US FDA Preferred Term for this commodity. Mazokalim bears US NLM identifiers UMLS ID C2827250 and NCI Concept Code C83907. SMILES: O1C(C(O)(C(Oc2n[nH]c(=O)cc2)c2c1ccc(c2)c1n(nnn1)CCCC(=O)OCC)C)(C)C.